Sudarshan Sukhani, s2analytics.com is of the view that Aurobindo Pharma has target of Rs 215. “Binani Industries is not an outperforming stock. So, I would be very happy if I don‘t own this share,†he adds.
first published: Jan 3, 2013 12:08 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty recovers 100 pts from day's low, metals under pressure | Closing Bell

Govt to stick to the path of fiscal consolidation - Prof Dev, PMEC chairman

Budget 2026 expectations: Taxpayers eye higher standard deduction, home loan interest relief

Live: Will Nifty take a breather after 3-day rally amid mixed global cues | Opening Bell
You are already a Moneycontrol Pro user.